Loading viewer...
conference
Format: PDF conference
Clearside Biomedical presented its suprachoroidal space (SCS) platform for targeted retinal and choroidal disease therapy at the 2017 Cowen Health Care Conference. The company showcased positive Phase 2 clinical data in retinal vascular disease and ocular inflammatory disease, with Phase 3 trials underway in retinal vein occlusion and uveitis, targeting diseases including diabetic macular edema and wet AMD.
presentation
conference
62 Pages
Ryerson Holding Corporation
Ryerson Holding 2023 J.P. Morgan Industrials Conference
conferenceconference
64 Pages
Ryerson Holding Corporation
IAC 2024 Abstract Submission FAQs Guide
conferenceconference
3 Pages
International Astronautical Federation